Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The instrumental role of lipids in governing the sensitivity of multiple myeloma to ferroptosis. | Discov Oncol | 2025 | 40853521 | PubTator, text mining | PubMed |
| Treponema pallidum inhibits CD4+ T-cell proliferation through METAP2: insights from Mendelian randomization analysis. | AMB Express | 2025 | 40853519 | PubTator, text mining | PubMed |
| A novel prognostic signature integrating disulfidptosis- and ferroptosis-related genes in acute myeloid leukemia. | Clin Exp Med | 2025 | 40853395 | PubTator, text mining | PubMed |
| Gene Expression Profiling of Advanced Stage Hepatocellular Carcinoma: A Bioinformatic Analysis. | Asian Pac J Cancer Prev | 2025 | 40849709 | PubTator, text mining | PubMed |
| Persistent lineage plasticity driving lung cancer development and progression. | Clin Transl Med | 2025 | 40847555 | PubTator, text mining | PubMed |
| Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers. | Mol Cancer | 2025 | 40847302 | PubTator, text mining | PubMed |
| SPI1 Transcriptional Activates TXNRD1 to Protect Trophoblast Cell from Ferroptosis. | Reprod Sci | 2025 | 40826214 | PubTator, text mining | PubMed |
| Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer. | NPJ Precis Oncol | 2025 | 40825842 | PubTator, text mining | PubMed |
| NRF2-dependent suppression of selenoprotein P expression promotes intracellular selenium metabolic remodeling and upregulation of antioxidant selenoproteins in hepatocellular carcinoma. | Redox Biol | 2025 | 40818321 | PubTator, text mining | PubMed |
| Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTs. | Sci Adv | 2025 | 40802750 | PubTator, text mining | PubMed |
| Estimating protein complex model accuracy using graph transformers and pairwise similarity graphs. | Bioinform Adv | 2025 | 40799498 | PubTator, text mining | PubMed |
| Microbial synergistic metabolic mechanism of enhanced tetrabromobisphenol A removal by bio-electrochemical system coupled constructed wetland. | J Hazard Mater | 2025 | 40779866 | PubTator, text mining | PubMed |
| Inhibitor fluorination pattern tunes chemically induced protein dimerization. | bioRxiv | 2025 | 40766609 | PubTator, text mining | PubMed |
| Thioredoxin Reductase 1 inhibition triggers ferroptosis in KRAS-independent lung cancers. | bioRxiv | 2025 | 40766571 | PubTator, text mining | PubMed |
| Hepatotoxicity evaluation of cannabidiol, cannabinol, cannabichromene and cannabigerol using a human quad culture liver chip. | Sci Rep | 2025 | 40750820 | PubTator, text mining | PubMed |
| METTL5 regulates SEPHS2-mediated selenoprotein synthesis to promote multiple myeloma survival and progression. | Cell Death Dis | 2025 | 40750759 | PubTator, text mining | PubMed |
| Anti-melanogenic and Antioxidant Activities of Lactiplantibacillus plantarum Strains in Skin Cells via the CREB/MITF and Nrf2/HO-1 Pathways. | Probiotics Antimicrob Proteins | 2025 | 40736668 | PubTator, text mining | PubMed |
| Ferroptosis: a novel pharmacological mechanism against multiple myeloma. | Front Pharmacol | 2025 | 40735482 | PubTator, text mining | PubMed |
| Early in vivo target genes in human immune cells highlight vitamin D's role in antioxidant defense. | Front Immunol | 2025 | 40735310 | PubTator, text mining | PubMed |
| N-substituted phthalimide-carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: Synthesis, mechanistic insights, and cancer-relevant profiling. | Bioorg Chem | 2025 | 40716159 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=12